- The report recognizes the following as the key players in the fallopian tube cancer therapeutics market AbbVie Inc., Amgen Inc., Baxter International Inc., Bristol Myers Squibb Co., and Clovis Oncology Inc. among others.
- The global fallopian tube cancer therapeutics market structure is concentrated in nature.
- North America to have a significant share in the fallopian tube cancer therapeutics market.
- Market to observe 6.44% YOY growth in 2022. View Sample Report Here.
Key Segments
The fallopian tube cancer therapeutics market is segmented by product (targeted therapy and chemotherapy).
The demand for targeted therapy has been significant in the market. These are small molecule-based drugs that are highly effective in inhibiting cell growth by entering cancer cells. Their high target affinity is the key factor in driving the growth of the segment.
Regional Growth Analysis
The global fallopian tube cancer therapeutics market is analyzed across four regions — North America, Europe, Asia, and Rest of World (ROW).
North America is currently the dominating region, occupying 39% of the global market share. The increasing adoption of therapeutics for the treatment of the indication is driving the growth of the regional market. In addition, the increasing number of patient assistance programs is expected further aid the growth of the fallopian tube cancer therapeutics market in North America during the forecast period.
Identify potential segments and regions to invest in over the forecast period. Read Sample Report Before Purchasing
Market Dynamics
The fallopian tube cancer therapeutics market is expected to witness substantial growth during the forecast period, primarily due to the growing attention toward women's health globally. Many organizations and governments across the globe are working on increasing awareness of the importance of diagnosis and treatment of fallopian tube cancer. For instance, the Office on Women Health, a part of the US Department of Health and Human Services is working on increasing awareness about the indication through various programs that educate people about the severity of the indication. It conducts the National Women Health Week during the third week of May every year, which focuses on promoting women's health in the US. The market is also witnessing an increase in the number of campaigns that primarily focus on women's health. Many such initiatives are resulting in an increased diagnosis of the indication, thereby fostering the growth of the market in focus.
The report also covers information on the upcoming trends and challenges that will influence the market growth. Explore the scope of the full report by Downloading a Sample Report.
Vendor Landscape
The fallopian tube cancer therapeutics market is concentrated. The market has a limited number of vendors with approved chemotherapies and four targeted therapies. However, over the forecast period, the market is expected to move toward fragmentation with the entry of new vendors and the increasing number of strategic alliances.
Here are some of the products offered by key vendors:
Amgen Inc.: The company offers coin sorter products such as CS2000-9P, CS2000-7P, and Detector L90C.
Bristol Myers Squibb Co.: The company offers coin sorter products such as JetSort 1000, JetSort 2000, and JetSort 3000.
Clovis Oncology Inc.: The company offers coin sorter products such as Zebra coin counter/sorter and Pelican coin counter/sorter.
Along with the market data, Technavio offers customizations as per the specific needs of companies. The following customization options are available for the fallopian tube cancer therapeutics market report:
Regional Analysis
- Further breakdown of the market segmentation at requested regions.
Market Player Information
- Detailed analysis and profiling of additional market players, vendor segmentation, and vendor offerings.
- Know the strategies adopted by vendors during the recovery phase.
Get your queries resolved by an industry expert. Speak to Our Analyst Now
Our customers who purchased this report also bought,
Fallopian Tube Cancer Therapeutics Market Scope |
Report Coverage |
Details |
Page number |
120 |
Base year |
2021 |
Forecast period |
2022-2026 |
Growth momentum & CAGR |
Accelerate at a CAGR of 9.06% |
Market growth 2022-2026 |
USD 628.28 million |
Market structure |
Concentrated |
YoY growth (%) |
6.44 |
Regional analysis |
North America, Europe, Asia, and Rest of World (ROW) |
Performing market contribution |
North America at 39% |
Key consumer countries |
US, Austria, Switzerland, China, and India |
Competitive landscape |
Leading companies, competitive strategies, consumer engagement scope |
Companies profiled |
AbbVie Inc., Amgen Inc., Baxter International Inc., Bristol Myers Squibb Co., Clovis Oncology Inc., Eli Lilly and Co., F. Hoffmann La Roche Ltd., GlaxoSmithKline Plc, ImmunoGen Inc., Johnson and Johnson, Merck and Co. Inc., and Novartis AG |
Market Dynamics |
Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID 19 impact and future consumer dynamics, and market condition analysis for the forecast period. |
Customization purview |
If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized. |
Table Of Contents :
1 Executive Summary
- 1.1 Market overview
- Exhibit 01: Executive Summary – Chart on Market Overview
- Exhibit 02: Executive Summary – Data Table on Market Overview
- Exhibit 03: Executive Summary – Chart on Global Market Characteristics
- Exhibit 04: Executive Summary – Chart on Market by Geography
- Exhibit 05: Executive Summary – Chart on Market Segmentation by Product
- Exhibit 06: Executive Summary – Chart on Incremental Growth
- Exhibit 07: Executive Summary – Data Table on Incremental Growth
- Exhibit 08: Executive Summary – Chart on Vendor Market Positioning
2 Market Landscape
- 2.1 Market ecosystem
- Exhibit 09: Parent market
- Exhibit 10: Market Characteristics
3 Market Sizing
- 3.1 Market definition
- Exhibit 11: Offerings of vendors included in the market definition
- 3.2 Market segment analysis
- Exhibit 12: Market segments
- 3.4 Market outlook: Forecast for 2021-2026
- Exhibit 13: Chart on Global - Market size and forecast 2021-2026 ($ million)
- Exhibit 14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
- Exhibit 15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
- Exhibit 16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
4 Five Forces Analysis
- 4.1 Five forces summary
- Exhibit 17: Five forces analysis - Comparison between 2021 and 2026
- 4.2 Bargaining power of buyers
- Exhibit 18: Chart on Bargaining power of buyers – Impact of key factors 2021 and 2026
- 4.3 Bargaining power of suppliers
- Exhibit 19: Bargaining power of suppliers – Impact of key factors in 2021 and 2026
- 4.4 Threat of new entrants
- Exhibit 20: Threat of new entrants – Impact of key factors in 2021 and 2026
- 4.5 Threat of substitutes
- Exhibit 21: Threat of substitutes – Impact of key factors in 2021 and 2026
- 4.6 Threat of rivalry
- Exhibit 22: Threat of rivalry – Impact of key factors in 2021 and 2026
- 4.7 Market condition
- Exhibit 23: Chart on Market condition - Five forces 2021 and 2026
5 Market Segmentation by Product
- 5.1 Market segments
- Exhibit 24: Chart on Product - Market share 2021-2026 (%)
- Exhibit 25: Data Table on Product - Market share 2021-2026 (%)
- 5.2 Comparison by Product
- Exhibit 26: Chart on Comparison by Product
- Exhibit 27: Data Table on Comparison by Product
- 5.3 Targeted therapy - Market size and forecast 2021-2026
- Exhibit 28: Chart on Targeted therapy - Market size and forecast 2021-2026 ($ million)
- Exhibit 29: Data Table on Targeted therapy - Market size and forecast 2021-2026 ($ million)
- Exhibit 30: Chart on Targeted therapy - Year-over-year growth 2021-2026 (%)
- Exhibit 31: Data Table on Targeted therapy - Year-over-year growth 2021-2026 (%)
- 5.4 Chemotherapy - Market size and forecast 2021-2026
- Exhibit 32: Chart on Chemotherapy - Market size and forecast 2021-2026 ($ million)
- Exhibit 33: Data Table on Chemotherapy - Market size and forecast 2021-2026 ($ million)
- Exhibit 34: Chart on Chemotherapy - Year-over-year growth 2021-2026 (%)
- Exhibit 35: Data Table on Chemotherapy - Year-over-year growth 2021-2026 (%)
- 5.5 Market opportunity by Product
- Exhibit 36: Market opportunity by Product ($ million)
6 Customer Landscape
- 6.1 Customer landscape overview
- Exhibit 37: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
7 Geographic Landscape
- 7.1 Geographic segmentation
- Exhibit 38: Chart on Market share by geography 2021-2026 (%)
- Exhibit 39: Data Table on Market share by geography 2021-2026 (%)
- 7.2 Geographic comparison
- Exhibit 40: Chart on Geographic comparison
- Exhibit 41: Data Table on Geographic comparison
- 7.3 North America - Market size and forecast 2021-2026
- Exhibit 42: Chart on North America - Market size and forecast 2021-2026 ($ million)
- Exhibit 43: Data Table on North America - Market size and forecast 2021-2026 ($ million)
- Exhibit 44: Chart on North America - Year-over-year growth 2021-2026 (%)
- Exhibit 45: Data Table on North America - Year-over-year growth 2021-2026 (%)
- 7.4 Europe - Market size and forecast 2021-2026
- Exhibit 46: Chart on Europe - Market size and forecast 2021-2026 ($ million)
- Exhibit 47: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
- Exhibit 48: Chart on Europe - Year-over-year growth 2021-2026 (%)
- Exhibit 49: Data Table on Europe - Year-over-year growth 2021-2026 (%)
- 7.5 Asia - Market size and forecast 2021-2026
- Exhibit 50: Chart on Asia - Market size and forecast 2021-2026 ($ million)
- Exhibit 51: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
- Exhibit 52: Chart on Asia - Year-over-year growth 2021-2026 (%)
- Exhibit 53: Data Table on Asia - Year-over-year growth 2021-2026 (%)
- 7.6 Rest of World (ROW) - Market size and forecast 2021-2026
- Exhibit 54: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
- Exhibit 55: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
- Exhibit 56: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
- Exhibit 57: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
- 7.7 US - Market size and forecast 2021-2026
- Exhibit 58: Chart on US - Market size and forecast 2021-2026 ($ million)
- Exhibit 59: Data Table on US - Market size and forecast 2021-2026 ($ million)
- Exhibit 60: Chart on US - Year-over-year growth 2021-2026 (%)
- Exhibit 61: Data Table on US - Year-over-year growth 2021-2026 (%)
- 7.8 Austria - Market size and forecast 2021-2026
- Exhibit 62: Chart on Austria - Market size and forecast 2021-2026 ($ million)
- Exhibit 63: Data Table on Austria - Market size and forecast 2021-2026 ($ million)
- Exhibit 64: Chart on Austria - Year-over-year growth 2021-2026 (%)
- Exhibit 65: Data Table on Austria - Year-over-year growth 2021-2026 (%)
- 7.9 China - Market size and forecast 2021-2026
- Exhibit 66: Chart on China - Market size and forecast 2021-2026 ($ million)
- Exhibit 67: Data Table on China - Market size and forecast 2021-2026 ($ million)
- Exhibit 68: Chart on China - Year-over-year growth 2021-2026 (%)
- Exhibit 69: Data Table on China - Year-over-year growth 2021-2026 (%)
- 7.10 Switzerland - Market size and forecast 2021-2026
- Exhibit 70: Chart on Switzerland - Market size and forecast 2021-2026 ($ million)
- Exhibit 71: Data Table on Switzerland - Market size and forecast 2021-2026 ($ million)
- Exhibit 72: Chart on Switzerland - Year-over-year growth 2021-2026 (%)
- Exhibit 73: Data Table on Switzerland - Year-over-year growth 2021-2026 (%)
- 7.11 India - Market size and forecast 2021-2026
- Exhibit 74: Chart on India - Market size and forecast 2021-2026 ($ million)
- Exhibit 75: Data Table on India - Market size and forecast 2021-2026 ($ million)
- Exhibit 76: Chart on India - Year-over-year growth 2021-2026 (%)
- Exhibit 77: Data Table on India - Year-over-year growth 2021-2026 (%)
- 7.12 Market opportunity by geography
- Exhibit 78: Market opportunity by geography ($ million)
8 Drivers, Challenges, and Trends
- 8.3 Impact of drivers and challenges
- Exhibit 79: Impact of drivers and challenges in 2021 and 2026
9 Vendor Landscape
- 9.2 Vendor landscape
- Exhibit 80: Overview on Criticality of inputs and Factors of differentiation
- 9.3 Landscape disruption
- Exhibit 81: Overview on factors of disruption
- 9.4 Industry risks
- Exhibit 82: Impact of key risks on business
10 Vendor Analysis
- 10.1 Vendors covered
- Exhibit 83: Vendors covered
- 10.2 Market positioning of vendors
- Exhibit 84: Matrix on vendor position and classification
- 10.3 Amgen Inc.
- Exhibit 85: Amgen Inc. - Overview
- Exhibit 86: Amgen Inc. - Product / Service
- Exhibit 87: Amgen Inc. - Key offerings
- 10.4 Baxter International Inc.
- Exhibit 88: Baxter International Inc. - Overview
- Exhibit 89: Baxter International Inc. - Business segments
- Exhibit 90: Baxter International Inc. - Key news
- Exhibit 91: Baxter International Inc. - Key offerings
- Exhibit 92: Baxter International Inc. - Segment focus
- 10.5 Bristol Myers Squibb Co.
- Exhibit 93: Bristol Myers Squibb Co. - Overview
- Exhibit 94: Bristol Myers Squibb Co. - Product / Service
- Exhibit 95: Bristol Myers Squibb Co. - Key offerings
- 10.6 Clovis Oncology Inc.
- Exhibit 96: Clovis Oncology Inc. - Overview
- Exhibit 97: Clovis Oncology Inc. - Business segments
- Exhibit 98: Clovis Oncology Inc. - Key offerings
- Exhibit 99: Clovis Oncology Inc. - Segment focus
- 10.7 Eli Lilly and Co.
- Exhibit 100: Eli Lilly and Co. - Overview
- Exhibit 101: Eli Lilly and Co. - Product / Service
- Exhibit 102: Eli Lilly and Co. - Key offerings
- 10.8 F. Hoffmann La Roche Ltd.
- Exhibit 103: F. Hoffmann La Roche Ltd. - Overview
- Exhibit 104: F. Hoffmann La Roche Ltd. - Business segments
- Exhibit 105: F. Hoffmann La Roche Ltd. - Key news
- Exhibit 106: F. Hoffmann La Roche Ltd. - Key offerings
- Exhibit 107: F. Hoffmann La Roche Ltd. - Segment focus
- 10.9 GlaxoSmithKline Plc
- Exhibit 108: GlaxoSmithKline Plc - Overview
- Exhibit 109: GlaxoSmithKline Plc - Business segments
- Exhibit 110: GlaxoSmithKline Plc - Key news
- Exhibit 111: GlaxoSmithKline Plc - Key offerings
- Exhibit 112: GlaxoSmithKline Plc - Segment focus
- 10.10 ImmunoGen Inc.
- Exhibit 113: ImmunoGen Inc. - Overview
- Exhibit 114: ImmunoGen Inc. - Product / Service
- Exhibit 115: ImmunoGen Inc. - Key offerings
- 10.11 Johnson and Johnson
- Exhibit 116: Johnson and Johnson - Overview
- Exhibit 117: Johnson and Johnson - Business segments
- Exhibit 118: Johnson and Johnson - Key news
- Exhibit 119: Johnson and Johnson - Key offerings
- Exhibit 120: Johnson and Johnson - Segment focus
- 10.12 Merck and Co. Inc.
- Exhibit 121: Merck and Co. Inc. - Overview
- Exhibit 122: Merck and Co. Inc. - Business segments
- Exhibit 123: Merck and Co. Inc. - Key news
- Exhibit 124: Merck and Co. Inc. - Key offerings
- Exhibit 125: Merck and Co. Inc. - Segment focus
11 Appendix
- 11.2 Inclusions and exclusions checklist
- Exhibit 126: Inclusions checklist
- Exhibit 127: Exclusions checklist
- 11.3 Currency conversion rates for US$
- Exhibit 128: Currency conversion rates for US$
- 11.4 Research methodology
- Exhibit 129: Research methodology
- Exhibit 130: Validation techniques employed for market sizing
- Exhibit 131: Information sources
- 11.5 List of abbreviations
- Exhibit 132: List of abbreviations
About Us
Technavio is a leading global technology research and advisory company. Their research and analysis focus on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio's report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio's comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.
Contact
Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: [email protected]
Website: www.technavio.com/
SOURCE Technavio
Share this article